# Retrospective analysis of reference intervals for dried blood spot based ms/ms newborn screening programs in Chinese preterm neonates: a nationwide study

**Authors:** Falin He, Tiancheng Xie, Xinwen Huang, Jinming Zhang, Tian Tang

PMC · DOI: 10.1186/s12887-024-04865-1 · BMC Pediatrics · 2024-07-02

## TL;DR

This study provides reference intervals for MS/MS newborn screening biomarkers in preterm Chinese infants, showing how birth weight, age, and sex affect these levels.

## Contribution

The study introduces the first comprehensive reference intervals for preterm neonates in MS/MS newborn screening, stratified by birth weight, age, and sex.

## Key findings

- Higher birth weight correlates with increased levels of several amino acids and long-chain acylcarnitines.
- Age significantly affects all MS/MS biomarker levels, while sex only influences one specific acylcarnitine in very low birth weight infants.
- Reference intervals were established for 35 biomarkers, aiding in the health assessment of preterm neonates.

## Abstract

Although recent discoveries regarding the biomarkers of newborn screening (NBS) programs by tandem mass spectrometry (MS/MS) highlight the critical need to establish reference intervals (RIs) specifically for preterm infants, no such RIs has been formally published yet. This study addressed the gap by offering a comprehensive set of reference intervals (RIs) for preterm neonates, and illustrating the dynamic changes of each biomarker with age.

The NBS data of 199,693 preterm newborns (< 37 weeks of gestation) who met the inclusion and exclusion criteria from the NNSCP database were included in study analysis. The birth weight stratified dynamic trend of each biomarker were captured by their concentrations over age. Reference partitions were determined by the method of Harris and Boyd. RIs, corresponding to the 2.5th and 97.5th percentiles, as well as the 0.5th, 25th, 50th, 75th and 99.5th percentiles were calculated using a non-parametric rank approach.

Increasing birth weight is associated with an elevation in the levels of arginine, citrulline, glycine, leucine and isobarics, methionine, ornithine, phenylalanine, and valine, whereas the levels of alanine, proline and tyrosine decrease. Additionally, two short-chain acylcarnitines (butyrylcarnitine + isobutyrylcarnitine and isovalerylcarnitine + methylbutyrylcarnitine) and a median-chain acylcarnitine (octenoylcarnitine) decrease, while four long-chain acylcarnitines (tetradecanoylcarnitine, palmitoylcarnitine, palmitoleylcarnitine and oleoylcarnitine) increase with increasing birth weight. Age impacts the levels of all MS/MS NBS biomarkers, while sex only affects the level of malonylcarnitine + 3-hydroxybutyrylcarnitine (C3-DC + C4-OH) in very low birth weight preterm neonates.

The current study developed reference intervals (RIs) specific to birth weight, age, and/or sex for 35 MS/MS biomarkers, which can help in the timely evaluation of the health and disease of preterm neonates.

The online version contains supplementary material available at 10.1186/s12887-024-04865-1.

## Linked entities

- **Chemicals:** arginine (PubChem CID 232), citrulline (PubChem CID 833), glycine (PubChem CID 750), leucine (PubChem CID 857), methionine (PubChem CID 876), ornithine (PubChem CID 389), phenylalanine (PubChem CID 994), valine (PubChem CID 1182), alanine (PubChem CID 239), proline (PubChem CID 614), tyrosine (PubChem CID 1153), butyrylcarnitine (PubChem CID 213144), isobutyrylcarnitine (PubChem CID 168379), isovalerylcarnitine (PubChem CID 169235), methylbutyrylcarnitine (PubChem CID 168654974), octenoylcarnitine (PubChem CID 129692230), tetradecanoylcarnitine (PubChem CID 53477791), palmitoylcarnitine (PubChem CID 461), palmitoleylcarnitine (PubChem CID 129852175), oleoylcarnitine (PubChem CID 6441392), malonylcarnitine (PubChem CID 91825606), 3-hydroxybutyrylcarnitine (PubChem CID 71464477)

## Full-text entities

- **Diseases:** MS (MESH:D009103)
- **Chemicals:** oleoylcarnitine (MESH:C026968), glycine (MESH:D005998), acylcarnitine (MESH:C116917), citrulline (MESH:D002956), methionine (MESH:D008715), isovalerylcarnitine (MESH:C027333), C4-OH (-), palmitoylcarnitine (MESH:D010172), butyrylcarnitine (MESH:C427065), ornithine (MESH:D009952), tyrosine (MESH:D014443), proline (MESH:D011392), isobutyrylcarnitine (MESH:C020381), alanine (MESH:D000409)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11220950/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11220950/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC11220950/full.md

---
Source: https://tomesphere.com/paper/PMC11220950